Eam Global Investors LLC Mannkind Corp Transaction History

Eam Global Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.02 - $5.37 $903,019 - $1.61 Million	299,013 New	299,013 $1.58 Million
Q2 2022 Aug 12, 2022	BUY	$2.67 - $4.77 $968,318 - $1.73 Million	362,666 New	362,666 $1.38 Million
Q2 2021 Aug 13, 2021	SELL	$3.61 - $5.45 $1.54 Million - $2.32 Million	-425,573 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$3.14 - $6.14 $871,042 - $1.7 Million	-277,402 Reduced 39.46%	425,573 $1.67 Million
Q4 2020 Feb 11, 2021	BUY	$1.79 - $4.04 $1.26 Million - $2.84 Million	702,975 New	702,975 $2.2 Million

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.75B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.